Last reviewed · How we verify
Fecal Microbiota Transplant; Vancomycin — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Fecal Microbiota Transplant; Vancomycin (Fecal Microbiota Transplant; Vancomycin) — ProgenaBiome.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Fecal Microbiota Transplant; Vancomycin TARGET | Fecal Microbiota Transplant; Vancomycin | ProgenaBiome | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Fecal Microbiota Transplant; Vancomycin CI watch — RSS
- Fecal Microbiota Transplant; Vancomycin CI watch — Atom
- Fecal Microbiota Transplant; Vancomycin CI watch — JSON
- Fecal Microbiota Transplant; Vancomycin alone — RSS
Cite this brief
Drug Landscape (2026). Fecal Microbiota Transplant; Vancomycin — Competitive Intelligence Brief. https://druglandscape.com/ci/fecal-microbiota-transplant-vancomycin. Accessed 2026-05-16.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab